Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 378

1.

Physical and chemical effects at rare-earth-metal-SiO2-Si structures.

Hofmann R, Henle WA, Öfner H, Ramsey MG, Netzer FP, Braun W, Horn K.

Phys Rev B Condens Matter. 1993 Apr 15;47(16):10407-10414. No abstract available.

PMID:
10005151
2.

Electronic structure of epitaxial Yb silicide.

Hofmann R, Henle WA, Netzer FP, Neuber M.

Phys Rev B Condens Matter. 1992 Aug 15;46(7):3857-3864. No abstract available.

PMID:
10004112
3.

Conduction bands of oxidized rare-earth-metal-silicon interfaces: An inverse-photoemission study.

Hofmann R, Henle WA, Netzer FP.

Phys Rev B Condens Matter. 1991 Aug 15;44(7):3133-3139. No abstract available.

PMID:
9999906
4.

Epstein-Barr virus and malignant lymphoepithelial lesions of the salivary gland.

Lanier AP, Clift SR, Bornkamm G, Henle W, Goepfert H, Raab-Traub N.

Arctic Med Res. 1991 Apr;50(2):55-61.

PMID:
1646614
5.

4f7-4f7 transitions in Gd, oxidized Gd, and epitaxial Gd silicide.

Matthew JA, Henle WA, Ramsey MG, Netzer FP.

Phys Rev B Condens Matter. 1991 Feb 15;43(6):4897-4901. No abstract available.

PMID:
9997862
6.

Reactions at the Gd-Si(111)7 x 7 interface: Promotion of Si oxidation.

Henle WA, Ramsey MG, Netzer FP, Cimino R, Braun W, Witzel S.

Phys Rev B Condens Matter. 1990 Dec 15;42(17):11073-11078. No abstract available.

PMID:
9995387
7.

Relationship between clinical stage, histopathology and antibody titers against the second Epstein-Barr virus nuclear antigen (EBNA-2) in non-Hodgkin's lymphoma patients.

Masucci G, Mellstedt H, Henle G, Henle W, Rymo L, Masucci MG, Ernberg I, Klein G.

Int J Cancer. 1989 Jun 15;43(6):1017-21.

PMID:
2543639
8.

Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition in infectious mononucleosis. II. Kinetics of sensitization against five EBV-encoded nuclear proteins and the latent membrane protein.

Szigeti R, Kallin B, Dillner J, Henle G, Henle W, Lerner RA, Rymo L, Timar L, Klein G.

Clin Immunol Immunopathol. 1989 Jun;51(3):396-405.

PMID:
2470542
9.

Severe thrombocytopenia in Epstein-Barr virus-induced mononucleosis.

Steeper TA, Horwitz CA, Moore SB, Henle W, Henle G, Ellis R, Flynn PJ.

West J Med. 1989 Feb;150(2):170-3.

10.

Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial.

Straus SE, Dale JK, Tobi M, Lawley T, Preble O, Blaese RM, Hallahan C, Henle W.

N Engl J Med. 1988 Dec 29;319(26):1692-8.

PMID:
2849717
11.

Heterophil-negative mononucleosis-like illnesses with atypical lymphocytosis in patients undergoing seroconversions to the human immunodeficiency virus.

Steeper TA, Horwitz CA, Hanson M, Henle W, Henle G, Rosenstein H, Peterson L, Amsden TW, Belzer M.

Am J Clin Pathol. 1988 Aug;90(2):169-74.

PMID:
3394657
12.
13.

Selected aspects of acute and chronic infectious mononucleosis and mononucleosis-like illnesses for the practicing allergist.

Steeper TA, Horwitz CA, Henle W, Henle G.

Ann Allergy. 1987 Oct;59(4):243-9. Review.

PMID:
3310748
14.

Salivary gland cancer in Alaskan natives, 1966-1980.

Krishnamurthy S, Lanier AP, Dohan P, Lanier JF, Henle W.

Hum Pathol. 1987 Oct;18(10):986-96. No abstract available. Erratum in: Hum Pathol 1988 Mar;19(3):328.

PMID:
2820863
15.

Stable transfection of a human lymphoma line by sub-genomic fragments of Epstein-Barr virus DNA to measure humoral and cellular immunity to the corresponding proteins.

Welinder C, Larsson NG, Szigeti R, Ehlin-Henriksson B, Henle G, Henle W, Klein G, Ricksten A, Rymo L, Sulitzeanu D.

Int J Cancer. 1987 Sep 15;40(3):389-95.

PMID:
3040603
16.

Rydberg wave packets in many-electron atoms excited by short laser pulses.

Henle WA, Ritsch H, Zoller P.

Phys Rev A Gen Phys. 1987 Jul 15;36(2):683-692. No abstract available.

PMID:
9898911
17.

Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein-Barr virus infection.

Miller G, Grogan E, Rowe D, Rooney C, Heston L, Eastman R, Andiman W, Niederman J, Lenoir G, Henle W, et al.

J Infect Dis. 1987 Jul;156(1):26-35.

PMID:
3036961
18.

Nuclear DNA-binding proteins determined by the Epstein-Barr virus-related simian lymphotropic herpesviruses H. gorilla, H. pan, H. pongo and H. papio.

Dillner J, Rabin H, Letvin N, Henle W, Henle G, Klein G.

J Gen Virol. 1987 Jun;68 ( Pt 6):1587-96.

PMID:
2438377
19.

Marked hyperbilirubinemia in infectious mononucleosis. Analysis of laboratory data in seven patients.

Fuhrman SA, Gill R, Horwitz CA, Henle W, Henle G, Kravitz G, Baldwin J, Tombers J.

Arch Intern Med. 1987 May;147(5):850-3.

PMID:
3034177
20.
21.

Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth.

Lewin N, Aman P, Masucci MG, Klein E, Klein G, Oberg B, Strander H, Henle W, Henle G.

Int J Cancer. 1987 Apr 15;39(4):472-6.

PMID:
3030940
22.

Analysis of Epstein-Barr virus-specific and non-specific immune functions in a patient during the development of a non-Hodgkin's lymphoma.

Masucci G, Mellstedt H, Masucci MG, Ernberg I, Szigeti R, Henle G, Henle W, Klein G.

Eur J Cancer Clin Oncol. 1987 Apr;23(4):379-86.

PMID:
3038561
23.

Acyclovir in accelerated phase of Chediak-Higashi syndrome.

Conley ME, Henle W.

Lancet. 1987 Jan 24;1(8526):212-3. No abstract available.

PMID:
2880031
24.

Acyclovir treatment in infectious mononucleosis: a clinical and virological study.

Andersson J, Sköldenberg B, Henle W, Giesecke J, Ortqvist A, Julander I, Gustavsson E, Akerlund B, Britton S, Ernberg I.

Infection. 1987;15 Suppl 1:S14-20.

PMID:
3036715
25.

Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection.

Henle W, Henle G, Andersson J, Ernberg I, Klein G, Horwitz CA, Marklund G, Rymo L, Wellinder C, Straus SE.

Proc Natl Acad Sci U S A. 1987 Jan;84(2):570-4.

26.

Serum antibodies to Epstein-Barr virus in patients with major depressive disorder.

Amsterdam JD, Henle W, Winokur A, Wolkowitz OM, Pickar D, Paul SM.

Am J Psychiatry. 1986 Dec;143(12):1593-6.

PMID:
3024514
27.

Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition (LMI) in infectious mononucleosis (IM). I. Kinetics and response to a membrane protein on EBV-transformed cells.

Szigeti R, Timar L, Weiland O, Henle W, Henle G, Hennessy K, Kieff E, Sulitzeanu D, Dillner J, Klein G.

Clin Immunol Immunopathol. 1986 Dec;41(3):342-50.

PMID:
3022972
28.

Absence of antibodies to the human immunodeficiency virus in sera from Africa prior to 1975.

Levy JA, Pan LZ, Beth-Giraldo E, Kaminsky LS, Henle G, Henle W, Giraldo G.

Proc Natl Acad Sci U S A. 1986 Oct;83(20):7935-7.

29.

An EBV genome carrying pre-B cell leukemia in a homosexual man with characteristic karyotype and impaired EBV-specific immunity.

Ernberg I, Björkholm M, Zech L, Sandstedt B, Szigeti R, Andersson J, Henle W, Klein G.

J Clin Oncol. 1986 Oct;4(10):1481-8.

PMID:
3020182
30.

Chronic active Epstein-Barr virus infection in patients with Chediak-Higashi syndrome.

Merino F, Henle W, Ramírez-Duque P.

J Clin Immunol. 1986 Jul;6(4):299-305.

PMID:
3018035
31.

Attachment of antinuclear antibodies to nasopharyngeal carcinoma or other cells during preparation of biopsy imprints.

Henle W, Henle G, Lanier AP, Bornkamm GW.

J Natl Cancer Inst. 1986 Jun;76(6):1041-6.

PMID:
3012176
32.

Chediak-Higashi syndrome: immunological responses to Epstein-Barr virus studies in gene heterozygotes.

Merino F, Amesty C, Henle W, Layrisse Z, Bianco N, Ramírez-Duque P.

J Clin Immunol. 1986 May;6(3):242-8.

PMID:
3013924
33.

Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serologic features and response to antiviral chemotherapy.

Schooley RT, Carey RW, Miller G, Henle W, Eastman R, Mark EJ, Kenyon K, Wheeler EO, Rubin RH.

Ann Intern Med. 1986 May;104(5):636-43.

PMID:
3008616
34.

Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells.

Kallin B, Dillner J, Ernberg I, Ehlin-Henriksson B, Rosén A, Henle W, Henle G, Klein G.

Proc Natl Acad Sci U S A. 1986 Mar;83(5):1499-503.

35.

Clinical and laboratory evaluation of cytomegalovirus-induced mononucleosis in previously healthy individuals. Report of 82 cases.

Horwitz CA, Henle W, Henle G, Snover D, Rudnick H, Balfour HH Jr, Mazur MH, Watson R, Schwartz B, Muller N.

Medicine (Baltimore). 1986 Mar;65(2):124-34.

PMID:
3005799
36.

The Epstein-Barr virus determined nuclear antigen is composed of at least three different antigens.

Dillner J, Kallin B, Ehlin-Henriksson B, Rymo L, Henle W, Henle G, Klein G.

Int J Cancer. 1986 Feb 15;37(2):195-200.

PMID:
2417963
37.

Effect of acyclovir on infectious mononucleosis: a double-blind, placebo-controlled study.

Andersson J, Britton S, Ernberg I, Andersson U, Henle W, Sköldenberg B, Tisell A.

J Infect Dis. 1986 Feb;153(2):283-90.

PMID:
3003206
38.

IgA antibodies to Epstein-Barr virus in infectious mononucleosis.

Marklund G, Henle W, Henle G, Ernberg I.

Scand J Infect Dis. 1986;18(2):111-9.

PMID:
3010447
39.

Differences in EBV-specific antibody patterns at onset of infectious mononucleosis.

Marklund G, Ernberg I, Lundberg C, Henle W, Henle G.

Scand J Infect Dis. 1986;18(1):25-32.

PMID:
3008309
40.

Epstein-Barr virus infection and serological profile in Greenland Eskimo children.

Albeck H, Bille T, Fenger HJ, Narvestad U, Sørensen GS, Henle G, Henle W, Højgaard Nielsen N, Hart Hansen JP.

Acta Paediatr Scand. 1985 Sep;74(5):691-6.

PMID:
2996288
41.

High prevalence of antibodies to acquired immune deficiency syndrome (AIDS)-associated retrovirus (ARV) in AIDS and related conditions but not in other disease states.

Kaminsky LS, McHugh T, Stites D, Volberding P, Henle G, Henle W, Levy JA.

Proc Natl Acad Sci U S A. 1985 Aug;82(16):5535-9.

42.

Long-term serological follow-up of patients for Epstein-Barr virus after recovery from infectious mononucleosis.

Horwitz CA, Henle W, Henle G, Rudnick H, Latts E.

J Infect Dis. 1985 Jun;151(6):1150-3. No abstract available.

PMID:
2987370
43.

Association of Epstein-Barr virus with thymic carcinoma.

Leyvraz S, Henle W, Chahinian AP, Perlmann C, Klein G, Gordon RE, Rosenblum M, Holland JF.

N Engl J Med. 1985 May 16;312(20):1296-9. No abstract available.

PMID:
2985993
44.

Quantitative analysis of immunosuppression in cyclosporine-treated heart transplant patients with lymphoma.

Brumbaugh J, Baldwin JC, Stinson EB, Oyer PE, Jamieson SW, Bieber CP, Henle W, Shumway NE.

J Heart Transplant. 1985 May;4(3):307-11.

PMID:
3039097
45.
46.

Antibody responses to two Epstein-Barr virus nuclear antigens defined by gene transfer.

Miller G, Grogan E, Fischer DK, Niederman JC, Schooley RT, Henle W, Lenoir G, Liu CR.

N Engl J Med. 1985 Mar 21;312(12):750-5.

PMID:
2983211
47.

Acyclovir treatment in primary Epstein-Barr virus infection. A double-blind placebo-controlled study.

Andersson J, Sköldenberg B, Ernberg I, Britton S, Henle W, Andersson U.

Scand J Infect Dis Suppl. 1985;47:107-15.

PMID:
3006226
48.

Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.

Berkel AI, Henle W, Henle G, Ersoy F, Sanal O, Klein G, Yeğin O.

Kroc Found Ser. 1985;19:287-300.

PMID:
2999343
49.

Epstein-Barr virus and blood transfusions.

Henle W, Henle G.

Prog Clin Biol Res. 1985;182:201-9. Review. No abstract available.

PMID:
2994098
50.

Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection.

Straus SE, Tosato G, Armstrong G, Lawley T, Preble OT, Henle W, Davey R, Pearson G, Epstein J, Brus I, et al.

Ann Intern Med. 1985 Jan;102(1):7-16.

PMID:
2578268

Supplemental Content

Support Center